24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease

Clinical trial NCT02579252 · COMPLETED

Trial details

NCT number: NCT02579252
Sponsor: Axon Neuroscience SE
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2016-03-01
Primary completion: 2019-06-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.